In this report, we revealed that the CD248+CAFs released IL‐8 in NSCLC, which, in turn, enhanced cisplatin IC50, while decreasing apoptosis of A549 and NCI‐H460 cells in vitro. Here, CXCL8 is linked to non-small cell lung carcinoma.